Literature DB >> 21726416

Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.

Walid Fayad1, Linda Rickardson, Caroline Haglund, Maria Hägg Olofsson, Padraig D'Arcy, Rolf Larsson, Stig Linder, Mårten Fryknäs.   

Abstract

Cell-based anticancer drug screening generally utilizes rapidly proliferating tumour cells grown as monolayer cultures. Hit compounds from such screens are not necessarily effective on hypoxic and slowly proliferating cells in 3-D tumour tissue. The aim of this study was to examine the potential usefulness of 3-D cultured tumour cells for anticancer drug screening. We used colon carcinoma multicellular spheroids containing hypoxic and quiescent cells in core areas for this purpose. Three libraries (∼11 000 compounds) were screened using antiproliferative activity and/or apoptosis as end-points. Screening of monolayer and spheroid cultures was found to identify different sets of hit compounds. Spheroid screening enriched for hydrophobic compounds: median XLogP values of 4.3 and 4.4 were observed for the hits in two independent screening campaigns. Mechanistic analysis revealed that the majority of spheroid screening hits were microtubuli inhibitors. One of these inhibitors was examined in detail and found to be effective against non-dividing cells in the hypoxic centres of spheroids. Spheroid screening represents a conceptually new strategy for anticancer drug discovery. Our findings have implications for drug library design and hit selection in projects aimed to develop drugs for the treatment of solid tumours.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726416     DOI: 10.1111/j.1747-0285.2011.01170.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  18 in total

1.  Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.

Authors:  Jeff Hirst; Harsh B Pathak; Stephen Hyter; Ziyan Y Pessetto; Thuc Ly; Stefan Graw; Devin C Koestler; Adam J Krieg; Katherine F Roby; Andrew K Godwin
Journal:  Cancer Res       Date:  2018-06-11       Impact factor: 12.701

2.  Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma.

Authors:  Malin Jarvius; Mårten Fryknäs; Frida Ek; Kristin Blom; Tove Selvin; Jakob Rudfeldt; Claes Andersson; Wojciech Senkowski; Christian Brechot; Peter Nygren; Rolf Larsson
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

3.  Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro.

Authors:  Jessica D Hess; Luca H Macias; Denisse A Gutierrez; Karla Moran-Santibanez; Lisett Contreras; Stephanie Medina; Paulina J Villanueva; Robert A Kirken; Armando Varela-Ramirez; Manuel L Penichet; Renato J Aguilera
Journal:  Biology (Basel)       Date:  2022-06-18

Review 4.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

5.  Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries.

Authors:  Xiaonan Zhang; Mihir Shetty; Valentino Clemente; Stig Linder; Martina Bazzaro
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

6.  Tissue dynamics spectroscopy for phenotypic profiling of drug effects in three-dimensional culture.

Authors:  David D Nolte; Ran An; John Turek; Kwan Jeong
Journal:  Biomed Opt Express       Date:  2012-10-15       Impact factor: 3.732

7.  Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening.

Authors:  Naris Nilubol; Lisa Zhang; Min Shen; Ya-Qin Zhang; Mei He; Christopher P Austin; Electron Kebebew
Journal:  J Transl Med       Date:  2012-09-21       Impact factor: 5.531

Review 8.  Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.

Authors:  Xiaonan Zhang; Angelo de Milito; Maria Hägg Olofsson; Joachim Gullbo; Padraig D'Arcy; Stig Linder
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

9.  Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance.

Authors:  Mårten Fryknäs; Joachim Gullbo; Xin Wang; Linda Rickardson; Malin Jarvius; Malin Wickström; Saadia Hassan; Claes Andersson; Mats Gustafsson; Gunnar Westman; Peter Nygren; Stig Linder; Rolf Larsson
Journal:  BMC Cancer       Date:  2013-08-06       Impact factor: 4.430

10.  Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.

Authors:  Xiaonan Zhang; Mårten Fryknäs; Emma Hernlund; Walid Fayad; Angelo De Milito; Maria Hägg Olofsson; Vladimir Gogvadze; Long Dang; Sven Påhlman; Leoni A Kunz Schughart; Linda Rickardson; Padraig D'Arcy; Joachim Gullbo; Peter Nygren; Rolf Larsson; Stig Linder
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.